North America self-injection market is expected to reach USD 23,540.98 million by 2024 from USD 10,228.89 million in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024.
Based on geography, the North America self-injection market is segmented into 5 geographical regions, such as,

U.S.,
Mexico,
Canada,

North America self-injection market competition by top players including -
Becton, Dickinson and Company is the major player in the United States for self-injection market as it has done lot of merger and acquisitions, partnerships and expansion. Some of the prominent players in the self-injection market include
Novo Nordisk,
Sanofi,
Pfizer,
Mylan N.V.,
Gerresheimer AG,
West Pharmaceutical Services, Inc.,
Ypsomed, Antares Pharma,
UNILIFE CORPORATION

The North America self-injection market is segmented on the basis of product type, application, usage pattern, mode of administration, end user, distribution channel and geography.
The global self injection market is segmented into 4 types, namely needle free injectors (NFI), auto injectors, pen injectors, and wearable injectors. In 2017, needle free injector market segment is expected to account for the largest share of 44.8%.

On the basis of applications, the global self-injection market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.

On the basis of usage pattern the global self-injection market is segmented into curative care, immunization.
Based on mode of administration the market is segmented into skin, circulatory, organs and central nervous system.
On the basis of end user the global self-injection market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies. In 2017 hospitals and clinics segment dominated the market and the trend is expected to remain the same till 2024.

Based on distribution channel, global self injection market is segmented into Pharmacy stores, direct tender, hospital pharmacy, and online pharmacy.